Chaoju Eye Care Holdings Limited

SEHK:2219 Stock Report

Market Cap: HK$2.6b

Chaoju Eye Care Holdings Management

Management criteria checks 4/4

Chaoju Eye Care Holdings' CEO is Bozhou Zhang, appointed in Dec 2020, has a tenure of 3.42 years. total yearly compensation is CN¥1.18M, comprised of 52.7% salary and 47.3% bonuses, including company stock and options. directly owns 14.73% of the company’s shares, worth HK$382.10M. The average tenure of the management team and the board of directors is 4 years and 4 years respectively.

Key information

Bozhou Zhang

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentage52.7%
CEO tenure3.4yrs
CEO ownership14.7%
Management average tenure4yrs
Board average tenure4yrs

Recent management updates

Recent updates

Chaoju Eye Care Holdings (HKG:2219) Will Pay A Larger Dividend Than Last Year At CN¥0.2975

Apr 24
Chaoju Eye Care Holdings (HKG:2219) Will Pay A Larger Dividend Than Last Year At CN¥0.2975

Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Have Been Accounted For Conservatively

Apr 02
Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Have Been Accounted For Conservatively

Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year

Apr 01
Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year

An Intrinsic Calculation For Chaoju Eye Care Holdings Limited (HKG:2219) Suggests It's 20% Undervalued

Jul 10
An Intrinsic Calculation For Chaoju Eye Care Holdings Limited (HKG:2219) Suggests It's 20% Undervalued

Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year

Jun 07
Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year

Earnings Report: Chaoju Eye Care Holdings Limited Missed Revenue Estimates By 7.9%

Mar 31
Earnings Report: Chaoju Eye Care Holdings Limited Missed Revenue Estimates By 7.9%

A Look At The Fair Value Of Chaoju Eye Care Holdings Limited (HKG:2219)

Feb 28
A Look At The Fair Value Of Chaoju Eye Care Holdings Limited (HKG:2219)

Chaoju Eye Care Holdings (HKG:2219) Could Be Struggling To Allocate Capital

Feb 06
Chaoju Eye Care Holdings (HKG:2219) Could Be Struggling To Allocate Capital

Chaoju Eye Care Holdings (HKG:2219) Is Reinvesting At Lower Rates Of Return

Aug 31
Chaoju Eye Care Holdings (HKG:2219) Is Reinvesting At Lower Rates Of Return

We Think Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Are Understated

Apr 04
We Think Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Are Understated

CEO Compensation Analysis

How has Bozhou Zhang's remuneration changed compared to Chaoju Eye Care Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

CN¥229m

Sep 30 2023n/an/a

CN¥232m

Jun 30 2023n/an/a

CN¥235m

Mar 31 2023n/an/a

CN¥211m

Dec 31 2022CN¥1mCN¥620k

CN¥188m

Sep 30 2022n/an/a

CN¥186m

Jun 30 2022n/an/a

CN¥184m

Mar 31 2022n/an/a

CN¥173m

Dec 31 2021CN¥1mCN¥512k

CN¥162m

Sep 30 2021n/an/a

CN¥163m

Jun 30 2021n/an/a

CN¥164m

Mar 31 2021n/an/a

CN¥144m

Dec 31 2020CN¥1mCN¥495k

CN¥124m

Dec 31 2019CN¥1mCN¥475k

CN¥76m

Dec 31 2018CN¥603kCN¥473k

CN¥39m

Compensation vs Market: Bozhou's total compensation ($USD162.41K) is below average for companies of similar size in the Hong Kong market ($USD423.87K).

Compensation vs Earnings: Bozhou's compensation has been consistent with company performance over the past year.


CEO

Bozhou Zhang (60 yo)

3.4yrs

Tenure

CN¥1,176,000

Compensation

Mr. Bozhou Zhang is Chief Executive Officer of Chaoju Eye Care Holdings Limited since December 21, 2020 and its Chairman since May 19, 2020. He joined Chaoju Eye Care Holdings in September 1990. Mr. Bozhou...


Leadership Team

NamePositionTenureCompensationOwnership
Bozhou Zhang
Chairman & CEO3.4yrsCN¥1.18m14.73%
CN¥ 382.1m
Xiaoli Zhang
Executive Director4yrsCN¥1.33m12.51%
CN¥ 324.4m
Guangdi Zhang
Executive Director4yrsCN¥624.00kno data
Junfeng Zhang
Executive Director4yrsCN¥377.00k8.9%
CN¥ 230.9m
Weichao Wang
Chief Financial Officer6.2yrsno datano data
Hongyan Liu
Chief Operating Officer6.5yrsno datano data
Yajun Yang
Chief Medical Officer6.4yrsno datano data
Ching Kit Cheng
Joint Company Secretary3.4yrsno datano data
Chun Xie
Joint Company Secretary2.3yrsno datano data

4.0yrs

Average Tenure

51yo

Average Age

Experienced Management: 2219's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bozhou Zhang
Chairman & CEO4yrsCN¥1.18m14.73%
CN¥ 382.1m
Xiaoli Zhang
Executive Director4yrsCN¥1.33m12.51%
CN¥ 324.4m
Guangdi Zhang
Executive Director4yrsCN¥624.00kno data
Junfeng Zhang
Executive Director4yrsCN¥377.00k8.9%
CN¥ 230.9m
Zhen Li
Non-Executive Director4yrsno datano data
Chen Mao
Non-Executive Director4yrsno datano data
Mingguang He
Independent Non-Executive Director2.8yrsCN¥205.00kno data
Hongyan Guo
Independent Non-Executive Director2.8yrsCN¥205.00kno data
Jianbin Li
Independent Non-Executive Director2.8yrsCN¥205.00kno data
Shan Bao
Independent Non-Executive Director2.8yrsCN¥205.00kno data
Zhang Li
Non-Executive Directorless than a yearno datano data

4.0yrs

Average Tenure

53yo

Average Age

Experienced Board: 2219's board of directors are considered experienced (4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.